States / U.S. Congress / HRES 803

HRES 803 In Committee

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber
House
Introduced
Oct 10, 2025
Last action
Oct 10, 2025 — Submitted in House
Session
119
Momentum
45 · Moderate